Showing results (221-230 of 314) with videos related to
Sort By:
Pageof 32
Molecular Cancer Therapeutics|December 17, 2002
Attenuated recombinant vaccinia virus expressing oncofetal antigen (tumor-associated antigen) 5T4 induces active therapy of established tumorsKate Mulryan, Matthew G Ryan, Kevin A Myers, et al.Biotechnology Progress|February 12, 2017
Evaluation of heavy chain C-terminal deletions on productivity and product quality of monoclonal antibodies in Chinese hamster ovary (CHO) cellsZhilan Hu, Danming Tang, Shahram Misaghi, et al.Biotechnology Progress|September 24, 2017
Beating the odds: The poisson distribution of all input cells during limiting dilution grossly underestimates whether a cell line is clonally-derived or notYizhou Zhou, David Shaw, Cynthia Lam, et al.Analytical Chemistry|July 25, 2024
Analytical and Functional Characterization of Plasmid DNA Topological Forms and MultimersDaniel Ngoc Nguyen, Peggy Ko, Brian Roper, et al.Chemical Biology & Drug Design|February 18, 2009
Structural insights for design of potent spleen tyrosine kinase inhibitors from crystallographic analysis of three inhibitor complexesArmando G Villaseñor, Rama Kondru, Hoangdung Ho, et al.Human Vaccines|February 28, 2009
Priming of CD4+ and CD8+ T cell responses using a HCV core ISCOMATRIX vaccine: a phase I study in healthy volunteersDebbie Drane, Eugene Maraskovsky, Rebecca Gibson, et al.Journal of Medical Virology|October 27, 2009
Application of an allele-specific PCR to clinical HIV genotyping samples detects additional K103N mutations in both therapy naïve and experienced patientsJillian M Carr, Tara Green, David Shaw, et al.Nuclear Medicine and Biology|May 10, 2005
Functional comparison of annexin V analogues labeled indirectly and directly with iodine-124Bronwen Dekker, Heather Keen, David Shaw, et al.Biochemistry|December 7, 2007
Steady state kinetics of spleen tyrosine kinase investigated by a real time fluorescence assayEva Papp, Joyce K Y Tse, Hoangdung Ho, et al.Neuropharmacology|December 19, 2003
Subtype-selective GABAergic drugs facilitate extinction of mouse operant behaviourCiara McCabe, David Shaw, John R Atack, et al.Pageof 32